| Issue price | |
| Initial fixing date | |
| Payment day | |
| First trading day | |
| Last trading day | |
| Final fixing day | |
| Redemption date | |
| Redemption type | |
| Early redemption | |
| Residual term | 0 |
| Issue amount |
| Price status | |
| Exchange | |
| Trade time | 09:15 - 17:15 (CET) |
| Round lot | |
| Performance of underlying since issue |
| SSPA derivative category | |
| SSPA code | () |
| Issuer | |
| Keep-Well Agreement | |
| Issuer rating | |
| Lead manager | |
| Payment, execution and calculation agent |
| Income tax | n.a. |
| Withholding tax | |
| Stamp duty payable in the secondary market | |
| Stamp duty payable upon delivery of the securities | |
| SIX Telekurs EU tax classification code | |
| Internal Rate of Return | |
| Cash value of fixed income investment upon issue | |
| Cash value of fixed income investment upon redemption |
| Redemption date | |
| Redemption amount | |
| Redemption currency | |
| Underlying | |
| Physical delivery | - |
| ZKB Barrier Reverse Convertible on worst of UBS Group AG/Helvetia Baloise Holding/Swiss Life Holding... 151092812 / CH1510928125 |
| ZKB Barrier Reverse Convertible on worst of Novartis AG/Geberit AG/UBS Group AG 151092088 / CH1510920882 |
| ZKB Callable Barrier Reverse Convertible on worst of Nestlé AG/Barry Callebaut AG/UBS Group AG/EMS-C... 149283732 / CH1492837328 |
| 10.0404% p.a. ZKB Callable Barrier Reverse Convertible, 19.08.2027 on worst of NESN SE/NOVN SE/ROP S... 151093164 / CH1510931640 |
| 9% p.a. ZKB Barrier Reverse Convertible, 23.02.2027 on worst of NOVN SE/ROP SE/UBSG SE 151093266 / CH1510932663 |